ROBO Global Healthcare Technology and Innovation ETF Rating $43.34 -0.30 (-0.69%) Closing price 09/23/2026 04:10 PM EasternExtended Trading$43.33 -0.01 (-0.02%) As of 09/23/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsNews and TrendsOwnershipRatings ROBO Global Healthcare Technology and Innovation ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.HTEC Aggregate RatingModerate Buy 2.61Holdings in HTEC have an aggregate rating of Moderate Buy based on 397 analyst ratings issued in the past year covering 22 companies (46.7% of the portfolio).HTEC Aggregate Price Target$43.34High Prediction$43.34Average Prediction$43.34Low Prediction$43.34Holdings in HTEC have an aggregate price target of $43.34 and a range of $43.34 to $43.34 covering 22 companies (46.7% of the portfolio).HTEC Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ROBO Global Healthcare Technology and Innovation ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 22 HTEC Holdings ExportWeight In ETFCompanyShare PriceConsensus RatingConsensus Price TargetPossible UpsideNumber of RatingsMarketRank™Indicator(s)ViewRatings3.68%MRNAModerna$182.11-0.2%Hold$76.72 -57.9%241.9951 of 5 starsTrending NewsAnalyst Forecast3.04%TWSTTwist Bioscience$158.50-3.7%Moderate Buy$103.00 -35.0%121.6561 of 5 starsTrending NewsAnalyst ForecastInsider Trade2.98%CDNACareDx$54.31-3.9%Moderate Buy$51.20 -5.7%82.7725 of 5 stars2.64%NTRANatera$390.790.0%Moderate Buy$330.83 -15.3%231.596 of 5 starsTrending News2.22%GHGuardant Health$176.31-0.5%Moderate Buy$188.13 6.7%262.1762 of 5 stars2.20%IQVIQVIA$268.05-0.8%Moderate Buy$248.00 -7.5%173.4635 of 5 stars2.16%TMOThermo Fisher Scientific$665.77+1.1%Moderate Buy$624.64 -6.2%263.7748 of 5 starsTrending News2.15%ADPTAdaptive Biotechnologies$27.89-0.6%Moderate Buy$27.07 -2.9%71.9107 of 5 starsAnalyst Forecast2.14%TEMTempus AI$76.59-0.8%Hold$69.63 -9.1%221.8659 of 5 starsAnalyst Forecast2.03%MEDPMedpace$617.15-2.1%Hold$595.20 -3.6%122.39 of 5 starsPositive NewsInsider Trade1.96%ILMNIllumina$255.38+3.2%Hold$199.13 -22.0%182.2032 of 5 stars1.93%VRTXVertex Pharmaceuticals$516.34+0.3%Moderate Buy$573.83 11.1%233.7826 of 5 starsTrending NewsAnalyst Forecast1.90%REGNRegeneron Pharmaceuticals$801.82-0.3%Moderate Buy$802.18 0.0%243.7127 of 5 starsAnalyst Forecast1.86%CRLCharles River Laboratories International$277.44-2.7%Moderate Buy$273.81 -1.3%151.9216 of 5 stars1.84%ARWRArrowhead Pharmaceuticals$66.96-6.8%Moderate Buy$99.15 48.1%142.6374 of 5 stars1.82%GKOSGlaukos$153.63-3.9%Moderate Buy$180.54 17.5%153.164 of 5 starsAnalyst Forecast1.76%GRALGRAIL$109.91+1.3%Hold$75.10 -31.7%120.9015 of 5 starsTrending NewsAnalyst ForecastInsider Trade1.74%LIVNLivaNova$77.16-1.7%Moderate Buy$84.13 9.0%112.5935 of 5 stars1.71%INCYIncyte$124.64-1.8%Moderate Buy$124.05 -0.5%253.1302 of 5 starsTrending NewsAnalyst Forecast1.70%AXGNAxoGen$43.32-2.7%Moderate Buy$51.56 19.0%122.4848 of 5 stars1.62%ABTAbbott Laboratories$103.62-0.1%Moderate Buy$119.50 15.3%274.8427 of 5 starsTrending NewsDividend Announcement1.61%DHRDanaher$221.80+0.3%Moderate Buy$229.32 3.4%243.5226 of 5 stars This page (NYSEARCA:HTEC) was last updated on 9/24/2026 by MarketBeat.com Staff. From Our PartnersHow to get a stake in Anthropic — before the IPOAnthropic, the maker of Claude AI, has reportedly filed for an IPO that could arrive as early as October. Its ...Weiss Ratings | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredWhy I believe the AI market will split in Q4Matt McCall, who recommended Nvidia near $6 a share, says the AI market is splitting in two - just like the do...The Oxford Club | SponsoredMy next big call (under $1)While the Senate was failing to pass the CLARITY Act, the SEC already had its own crypto framework on the tabl...Crypto 101 Media | SponsoredShocking new footage just releasedGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...Digest Publishing | SponsoredMajor Buy Alert Issued for September 30thKeith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...TradeSmith | SponsoredIf you keep cash in a U.S. bank account… read this NOWSince 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every d...Banyan Hill Publishing | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ROBO Global Healthcare Technology and Innovation ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share ROBO Global Healthcare Technology and Innovation ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
